GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (FRA:DMN) » Definitions » Inventory-to-Revenue

Diamyd Medical AB (FRA:DMN) Inventory-to-Revenue : 0.00 (As of Aug. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Diamyd Medical AB Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Diamyd Medical AB's Average Total Inventories for the quarter that ended in Aug. 2024 was €0.00 Mil. Diamyd Medical AB's Revenue for the three months ended in Aug. 2024 was €0.00 Mil. Diamyd Medical AB's Inventory-to-Revenue for the quarter that ended in Aug. 2024 was 0.00.

Diamyd Medical AB's Inventory-to-Revenue for the quarter that ended in Aug. 2024 stayed the same from May. 2024 (0.00) to May. 2024 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Diamyd Medical AB's Days Inventory for the three months ended in Aug. 2024 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Diamyd Medical AB Inventory-to-Revenue Historical Data

The historical data trend for Diamyd Medical AB's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Inventory-to-Revenue Chart

Diamyd Medical AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Diamyd Medical AB Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Diamyd Medical AB's Inventory-to-Revenue

For the Biotechnology subindustry, Diamyd Medical AB's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamyd Medical AB's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's Inventory-to-Revenue falls into.



Diamyd Medical AB Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Diamyd Medical AB's Inventory-to-Revenue for the fiscal year that ended in Aug. 2024 is calculated as

Inventory-to-Revenue (A: Aug. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Aug. 2023 ) + Total Inventories (A: Aug. 2024 )) / count ) / Revenue (A: Aug. 2024 )
=( (0 + 0) / 1 ) / 0.011
=0 / 0.011
=0.00

Diamyd Medical AB's Inventory-to-Revenue for the quarter that ended in Aug. 2024 is calculated as

Inventory-to-Revenue (Q: Aug. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: May. 2024 ) + Total Inventories (Q: Aug. 2024 )) / count ) / Revenue (Q: Aug. 2024 )
=( (0 + 0) / 1 ) / 0.002
=0 / 0.002
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamyd Medical AB  (FRA:DMN) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Diamyd Medical AB's Days Inventory for the three months ended in Aug. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Aug. 2024 )/Cost of Goods Sold (Q: Aug. 2024 )*Days in Period
=0/0.073*365 / 4
=0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Diamyd Medical AB's Inventory Turnover for the quarter that ended in Aug. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Aug. 2024 ) / Average Total Inventories (Q: Aug. 2024 )
=0.073 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamyd Medical AB Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamyd Medical AB Business Description

Traded in Other Exchanges
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.